Titlebook: Adjuvant Therapy for Breast Cancer; Monica Castiglione,Martine J. Piccart Book 2009 Springer-Verlag US 2009 Endocrine Therapy.Lapatinib.Ra

Folklore

無關(guān)緊要

鑲嵌細(xì)工

URN

乞丐

0927-3042 cancer survivor.Includes supplementary material: .Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much pro

勤勞

強(qiáng)壯

https://doi.org/10.1007/978-1-4419-0742-4uvant systemic therapy is currently recommended to most women with newly diagnosed breast cancer and is associated with declining mortality for women with breast cancer [2, 3]. Every year in the United States approximately 200,000 women are diagnosed with breast cancer [4].

follicle

0927-3042 gress towards a cure, including the introduction of new targeted therapies, metastasizing cancer remains highly incurable..978-1-4614-1716-3978-0-387-75115-3Series ISSN 0927-3042 Series E-ISSN 2509-8497

凹室

你敢命令

Springer Series in Reliability Engineering1, 2], and recent pivotal trials of adjuvant trastuzumab (Herceptin) demonstrated its benefit among patients whose tumors overexpressed HER2/. [3–5]. Exploration and improved understanding of the biological basis for predicting response to available adjuvant therapies is essential to enhance patient care.